Preclinical advantages of intramuscularly administered peptide A3-APO over existing therapies in Acinetobacter baumannii wound infections (Q34308017)
scientific article
Language:
(P31) (Q13442814)
(P50) (Q62516257)
(Q58137528)
(P304) 2416-2422
(P407) (Q1860)
(P433) 11
(P478) 65
(P577) Wednesday, September 1, 2010
(P921) (Q3241189)
(P1433) (Q6294770)
(P1476) "Preclinical advantages of intramuscularly administered peptide A3-APO over existing therapies in Acinetobacter baumannii wound infections" (language: en)
(P2093) Eszter Ostorhazi
Ferenc Rozgonyi
Andras Sztodola
Ferenc Harmos
Ilona Kovalszky
Dora Szabo
Daniel Knappe
Ralf Hoffmann
Marco Cassone
Laszlo Otvos
(P2860) (Q35462009)
(Q33593511)
(Q34443641)
(Q43209556)
(Q37595574)
(Q35002302)
(Q33608336)
(Q36740783)
(Q36972980)
(Q33294109)
(Q36885577)
(Q36800879)
(Q39077656)
(Q41823699)
(Q36214382)
(Q35903238)
(Q30759890)
(Q35137699)
(Q39649372)
(Q35005719)
(Q34547876)
(Q28131811)
(Q35548846)
(Q44169118)
(Q44718619)
(Q43253287)
(Q41891521)
(Q46633323)
(Q43895567)
(Q53998813)
(Q51023982)
(Q43115480)
(Q44273293)
(Q46623725)
(Q43547658)
(Q67559229)
(Q80372451)
(Q80479374)
other details
description scientific article

External Links